Live
- Lavu, Chadalavada file nominations
- Vizag to be developed on various fronts: Education Minister
- IIIT Hyd launches new dual degree programme in geospatial technology
- Rangareddy: MLA Veerlapalli Shankar inaugurates dance academy
- Hyderabad: Water board to roll out tanker-tracking app soon
- Ganta Srinivasa Rao files nomination at Bheemili
- Hyderabad: BITS Pilani ties up with BFI for biomed research
- Rangareddy: Deer fatally injured by dog succumbs
- TCS conducts placement drive at Loyola
- Hyderabad: BRAOU organises OU OER fest
Serum Institute pauses Coronavirus vaccine trials
Serum Institute pauses Coronavirus vaccine trials
The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University, on Thursday paused the clinical trials of the vaccine in India.
New Delhi: The Serum Institute of India (SII), which was conducting the India trials for the coronavirus vaccine being developed by Oxford University, on Thursday paused the clinical trials of the vaccine in India.
In a statement, the Serum Institute of India said: "We are reviewing the situation and pausing India trials till AstraZeneca restarts the trials. We are following DCGI's instructions and will not be able to comment further on trials." The declaration by the Pune-based vaccine manufacturer came a day after the Drug Control General of India (DCGI), VG Somani, issued a show-cause notice to them asking for an explanation as to why the institute decided to go ahead with the clinical trial of Covid-19 vaccine candidate while doubts about patient safety are yet unclear.
